These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 386314)
1. Improved results of secondary cadaver retransplantation. Thomas F; Mendez-Picon G; Mohanakumar T; Thomas J; Lee HM Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():212-8. PubMed ID: 386314 [No Abstract] [Full Text] [Related]
2. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies. Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845 [No Abstract] [Full Text] [Related]
3. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients. Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906 [No Abstract] [Full Text] [Related]
4. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy. Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892 [No Abstract] [Full Text] [Related]
5. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression. Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483 [No Abstract] [Full Text] [Related]
6. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation. Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417 [No Abstract] [Full Text] [Related]
7. [Correlation of serological and clinical compatibility in renal transplants--a study of 76 cases]. Piza F; Egert H; Kotzaurek R; Pausch V; Pacher M; Speiser P Wien Med Wochenschr; 1973 May; 123(19):298-301. PubMed ID: 4573952 [No Abstract] [Full Text] [Related]
8. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Thistlethwaite JR; Buckingham M; Stuart JK; Gaber AO; Mayes JT; Stuart FP Transplant Proc; 1987 Feb; 19(1 Pt 1):722-4. PubMed ID: 3079164 [No Abstract] [Full Text] [Related]
9. Histocompatibility testing in clinical renal transplantation. Braun WE Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529 [No Abstract] [Full Text] [Related]
10. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG). Thomas F; Mendez-Picon G; Thomas J; Lee HM Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531 [No Abstract] [Full Text] [Related]
11. Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantation. Fassbinder W; Bechstein PB; Stutte HJ; Scheuermann EH; Hanke P; Knöner M; Dathe G; Jonas D; Schoeppe W Neth J Med; 1985; 28(6):265-7. PubMed ID: 3892329 [No Abstract] [Full Text] [Related]
12. Prediction of kidney graft survival by sensitive crossmatch tests and the use of effector cell function (ECA) as a predictor of rejection. McConnachie PR; Finch WT; Birtch AG Transplant Proc; 1979 Jun; 11(2):1256-7. PubMed ID: 382501 [No Abstract] [Full Text] [Related]
13. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG? Geis WP; Giacchino JL; Buckingham JM; Bansal VK; Iwatsuki S; Kerman RH; Ing TS; Hano JE Transplant Proc; 1979 Jun; 11(2):1433-4. PubMed ID: 382533 [No Abstract] [Full Text] [Related]
14. A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement. Dormont J; Kreis H; Leski M; Bach JF; Crosnier J Rev Eur Etud Clin Biol; 1972 Apr; 17(4):382-9. PubMed ID: 4627946 [No Abstract] [Full Text] [Related]